Anti-toxoplasma activity and DNA-binding of copper(II) and zinc(II) coordination compounds with 5-nitroimidazole-based ligands.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Source:
      Publisher: Springer Country of Publication: Germany NLM ID: 9616326 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1327 (Electronic) Linking ISSN: 09498257 NLM ISO Abbreviation: J Biol Inorg Chem Subsets: MEDLINE
    • Publication Information:
      Original Publication: Berlin : Springer, c1996-
    • Subject Terms:
    • Abstract:
      Tetrahedral copper(II) and zinc(II) coordination compounds from 5-nitroimidazole derivatives, viz. 1-(2-chloroethyl)-2-methyl-5-nitroimidazole (cenz) and ornidazole 1-(3-chloro-2-hydroxypropyl)-2-methyl-5-nitroimidazole (onz), were synthesized and spectroscopically characterized. Their molecular structures were determined by X-ray diffraction studies. The complexes [Cu(onz) 2 X 2 ], [Zn(onz) 2 X 2 ], [Cu(cenz) 2 X 2 ] and [Zn(cenz) 2 X 2 ] (X -  = Cl, Br), are stable in solution and exhibit positive LogD 7.4 values that are in the range for molecules capable of crossing the cell membrane via passive difussion. Their biological activity against Toxoplasma gondi was investigated, and IC 50 and lethal dose (LD 50 ) values were determined. The ornidazole copper(II) compounds showed very good antiparasitic activity in its tachyzoite morphology. The interaction of the coordination compounds with DNA was examined by circular dichroism, fluorescence (using intercalating ethidium bromide and minor groove binding Hoechst 33258) and UV-Vis spectroscopy. The copper(II) compounds interact with the minor groove of the biomolecule, whereas weaker electrostatic interactions take place with the zinc(II) compounds. The spectroscopic data achieved for the two series of complexes (namely with copper(II) and zinc(II) as metal center) agree with the respective DNA-damage features observed by gel electrophoresis.
      (© 2023. The Author(s).)
    • References:
      Int J Parasitol. 2000 Nov;30(12-13):1217-58. (PMID: 11113252)
      Front Microbiol. 2018 Oct 29;9:2587. (PMID: 30420849)
      J Antimicrob Chemother. 1993 Jan;31(1):9-20. (PMID: 8444678)
      J Biol Inorg Chem. 2021 Sep;26(6):727-740. (PMID: 34453615)
      Biology (Basel). 2021 May 01;10(5):. (PMID: 34062712)
      Vet World. 2022 Jan;15(1):198-204. (PMID: 35369589)
      Dalton Trans. 2007 Mar 7;(9):955-64. (PMID: 17308676)
      Eur J Med Chem. 2010 Feb;45(2):817-24. (PMID: 19906466)
      Anim Health Res Rev. 2005 Jun;6(1):41-61. (PMID: 16164008)
      Antimicrob Agents Chemother. 2015 Dec;59(12):7374-86. (PMID: 26392498)
      Saudi J Biol Sci. 2020 Mar;27(3):812-819. (PMID: 32127756)
      Spectrochim Acta A Mol Biomol Spectrosc. 2012 Dec;99:18-22. (PMID: 23041917)
      DNA Cell Biol. 2010 Oct;29(10):639-46. (PMID: 20590475)
      Biomed Pharmacother. 2016 Aug;82:677-84. (PMID: 27470411)
      Sci Rep. 2021 May 4;11(1):9509. (PMID: 33947922)
      Dalton Trans. 2018 Jun 5;47(22):7551-7560. (PMID: 29790536)
      Zentralbl Veterinarmed A. 1999 Nov;46(9):517-22. (PMID: 10605360)
      RSC Adv. 2020 Jun 17;10(39):23286-23296. (PMID: 35520323)
      Arch Biochem Biophys. 2015 Jun 15;576:49-60. (PMID: 25951786)
      J Med Chem. 2020 Nov 25;63(22):13330-13354. (PMID: 32869995)
      J Med Chem. 2019 Mar 28;62(6):2851-2893. (PMID: 30295477)
      J Photochem Photobiol B. 2013 Jul 5;124:1-19. (PMID: 23648795)
      Vet Parasitol. 2017 Oct 15;245:141-152. (PMID: 28592362)
      Aliment Pharmacol Ther. 2000 Jan;14(1):7-14. (PMID: 10632640)
      J Inorg Biochem. 2017 Nov;176:159-167. (PMID: 28917638)
      Dalton Trans. 2023 Feb 14;52(7):2087-2097. (PMID: 36692493)
      J Appl Crystallogr. 2011 Dec 1;44(Pt 6):1281-1284. (PMID: 22477785)
      Biochem Pharmacol. 1986 Jan 1;35(1):53-8. (PMID: 3940526)
      J Int Assoc Provid AIDS Care. 2019 Jan-Dec;18:2325958219867315. (PMID: 31429353)
      Nat Rev Microbiol. 2021 Jul;19(7):467-480. (PMID: 33627834)
      Trends Parasitol. 2014 Jun;30(6):289-98. (PMID: 24776300)
      Eur J Pharm Sci. 2015 Aug 30;76:181-91. (PMID: 25968358)
      J Biol Inorg Chem. 2018 Oct;23(7):1165-1183. (PMID: 30076466)
      J Med Chem. 2017 Sep 28;60(18):7636-7657. (PMID: 28463485)
      Curr Protoc Mol Biol. 2006 Nov;Appendix 3:Appendix 3D. (PMID: 18265369)
      Lancet. 2004 Jun 12;363(9425):1965-76. (PMID: 15194258)
      Acta Crystallogr A. 2008 Jan;64(Pt 1):112-22. (PMID: 18156677)
      J Inorg Biochem. 2019 Sep;198:110749. (PMID: 31200320)
    • Grant Information:
      IN206922 DGAPA-Universidad Nacional Autónoma de México; 5000-9035 PAPIT-FQ- Universidad Nacional Autónoma de México; PID2019-107006GB-C21 Spanish Ministerio de Ciencia e Innovación; PID2020-115537RB-I00 Spanish Ministerio de Ciencia e Innovación; RED2018-102471-T Spanish Ministerio de Ciencia e Innovación
    • Contributed Indexing:
      Keywords: Anti-toxoplasma activity; Coordination compounds; Copper(II) and zinc(II); DNA-damage; Nitroimidazole ligands
    • Accession Number:
      Y8U32AZ5O7 (4-nitroimidazole)
      789U1901C5 (Copper)
      0 (Coordination Complexes)
      24AG2WW15W (2-methyl-5-nitroimidazole)
      J41CSQ7QDS (Zinc)
      62XCK0G93T (Ornidazole)
      9007-49-2 (DNA)
      0 (Ligands)
      0 (Nitroimidazoles)
    • Publication Date:
      Date Created: 20231215 Date Completed: 20240410 Latest Revision: 20240613
    • Publication Date:
      20240613
    • Accession Number:
      PMC11001709
    • Accession Number:
      10.1007/s00775-023-02029-7
    • Accession Number:
      38099935